Motivators and barriers affecting decisions to participate in sickle cell disease clinical trials in the global Learning and Insights into Sickle Cell Trial Experiences Survey

Research
Written By Christine Briscoe

Authors: Johnny Mahlangu, Raffaella Colombatti, John James, Cassandra Trimnell, John Waller, Samar Al-Behaisi, Adam Wufsus, Gareth Morrell, Biree Andemariam

Published: December 2025

Click Here to Read More
Christine Briscoe
Previous

Long-term follow-up of the first in human post-transcriptional genetic silencing of BCL11A in sickle cell disease in a phase 1 pilot and feasibility trial
Next

Increasing ketamine administration in children's hospitals for youth with sickle cell disease